Arbutus Biopharma Corp
- Last sale
- Nov 12, 2026 · +3.73%
- Market cap
- $617.77M
- 153.29M shares
- Filings
- 1,029
Q3 2026+128.2% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−50.4% FY25 yoy
- $617.77M
- 2.8×
- 3.4×
- 7.2×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $14,083,000 | reported | |
| FY 2024 | 2024-12-31 | $6,171,000 | reported | |
| FY 2023 | 2023-12-31 | $18,141,000 | reported | |
| FY 2022 | 2022-12-31 | $39,019,000 | reported | |
| FY 2021 | 2021-12-31 | $10,988,000 | reported | |
| FY 2020 | 2020-12-31 | $6,914,000 | reported | |
| FY 2019 | 2019-12-31 | $6,011,000 | reported | |
| FY 2018 | 2018-12-31 | $5,945,000 | reported | |
| FY 2017 | 2017-12-31 | $10,700,000 | reported | |
| FY 2016 | 2016-12-31 | $1,491,000 | reported | |
| FY 2015 | 2015-12-31 | $23,276,000 revised | reported | |
| FY 2014 | 2014-12-31 | $14,953,000 | reported |
Segments
Products
LineFY2025ShareChange
Collaborations and licenses$12.60M89%+221.5%
Non-cash royalty revenue$1.48M11%−34.2%
Total$14.08M
Pharmaceutical preparations
Arbutus Biopharma Corp is the 159th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
QUREuniQure N.V.$16.1M40.6%1,236.0%$1.7BIRDOpus Genetics, Inc.$14.2M29.1%349.3%$392.4M
ABUSArbutus Biopharma Corp (this company)$14.1M128.2%237.9%$617.8M
PYXSPyxis Oncology, Inc.$13.9M14.2%574.5%$189.0MCVSICV Sciences, Inc.$13.8M12.2%6.9%$2.4MPTNPalatin Technologies Inc$13.2M—63.5%$12.2MTNXPTonix Pharmaceuticals Holding Corp.$13.1M29.8%946.2%$62.6MEVMNEvommune, Inc.$13.0M85.7%529.8%$241.9MEMMAEmmaus Life Sciences, Inc.$12.5M25.2%60.2%$4.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Arbutus Biopharma Corp · CIK 1447028 · Engraved from SEC EDGAR